The diagnosis of endometrial carcinomas with clear cells by gynecologic pathologists: An assessment of interobserver variability and associated morphologic features

American Journal of Surgical Pathology

Volumn 36, Issue 8, 2012, Pages 1107-1118

  Fadare, Oluwole ^a   Parkash, Vinita ^b   Dupont, William D ^c   Acs, Geza ^d   Atkins, Kristen A ^e   Irving, Julie A ^f   Pirog, Edyta C ^g   Quade, Bradley J ^h   Ruhul Quddus, M ⁱ   Rabban, Joseph T ^j   Vang, Russell ^k   Hecht, Jonathan L ^l  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

^f ROYAL JUBILEE HOSPITAL   (Canada)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j BROWN UNIVERSITY   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l JOHNS HOPKINS HOSPITAL   (United States)

more..

Author keywords

endometrial clear cell carcinoma; interobserver reproducibility; interobserver variability

Indexed keywords

ADENOCARCINOMA; ARTICLE; CLASSIFICATION; ENDOMETRIUM TUMOR; FEMALE; GYNECOLOGY; HUMAN; OBSERVER VARIATION; PATHOLOGY; STANDARD;

ADENOCARCINOMA, CLEAR CELL; ENDOMETRIAL NEOPLASMS; FEMALE; GYNECOLOGY; HUMANS; OBSERVER VARIATION; PATHOLOGY, CLINICAL;

EID: 84863824916     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31825dd4b3     Document Type: Article

References (38)

1. De Bonneville HE. A few cases of carcinoma of the uterine corpus with too much glycogen [in German]. Virchow Arch Pathol Anat. 1911;204:201-209.
2. Elton NW. Morphologic variations in adenocarcinoma of the fundus of the uterus, with reference to secretory activity and clinical interpretations. Am J Clin Pathol. 1942;12:32-47.
3. Kay S. Clear-cell carcinoma of the endometrium. Cancer. 1957;10: 124-130.
4. Silverberg SG, De Giorgi LS. Clear cell carcinoma of the endometrium. Clinical, pathologic, and ultrastructural findings. Cancer. 1973;31:1127-1140.
5. Fechner RE. Endometrium with pattern of mesonephroma. Report of a case. Obstet Gynecol. 1968;31:485-490.
6. Kurman RJ, Scully RE. Clear cell carcinoma of the endometrium: an analysis of 21 cases. Cancer. 1976;37:872-882.
7. Clement PB, Young RH. Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol. 2004;11:117-142.
8. Silva EG, Deavers MT, Malpica A. Undifferentiated carcinoma of the endometrium: a review. Pathology. 2007;39:134-138.
9. Abeler VM, Vergote IB, Kjørstad KE, et al. Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern. Cancer. 1996; 78:1740-1747. (Pubitemid 26330902)
10. Christopherson WM, Alberhasky RC, Connelly PJ. Carcinoma of the endometrium: I. A clinicopathologic study of clear-cell carcinoma and secretory carcinoma. Cancer. 1982;49:1511-1523. (Pubitemid 12146934)
11. Creasman WT, Kohler MF, Odicino F, et al. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium. Gynecol Oncol. 2004;95:593-596. (Pubitemid 39610410)
12. Rauh-Hain JA, Costaaggini I, Olawaiye AB, et al. A comparison of outcome in patients with stage 1 clear cell and grade 3 endometrioid adenocarcinoma of the endometrium with and without adjuvant therapy. Eur J Gynaecol Oncol. 2010;31:284-287.
13. Carcangiu ML, Chambers JT. Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival. Int J Gynecol Pathol. 1995;14:30-38.
14. Fadare O. The molecular pathogenesis of endometrial clear cell carcinoma: unclear, uncertain and possibly heterogeneous. Expert Rev Obstet Gynecol. 2012;7:109-112.
15. Hecht JL, Mutter GL. Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol. 2006;24:4783-4791. (Pubitemid 46630943)
16. Fadare O, Zheng W. Insights into endometrial serous carcinogenesis. Int J Clin Exp Pathol. 2009;2:411-432.
17. An HJ, Logani S, Isacson C, et al. Molecular characterization of uterine clear cell carcinoma. Mod Pathol. 2004;17:530-537. (Pubitemid 38868419)
18. Varughese J, Hui P, Lu L, et al. Clear cell cancer of the uterine corpus: the association of clinicopathologic parameters and treatment on disease progression. J Oncol. 2011;2011:628084.
19. Carcangiu ML, Chambers JT. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol Oncol. 1992;47: 298-305. (Pubitemid 23011408)
20. DeLair D, Oliva E, Kö bel M, et al. Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases. Am J Surg Pathol. 2011;35:36-44.
21. Fleiss JL, Levin BA, Paik MC. Statistical Methods for Rates and Proportions. 3rd ed. Hoboken, NJ: J. Wiley; 2003.
22. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Uterine neoplasms. Version 2.2012. Available at: http://www.nccn.org. Accessed April 16, 2012.
23. Fadare O, Liang SX, Ulukus EC, et al. Precursors of endometrial clear cell carcinoma. Am J Surg Pathol. 2006;30:1519-1530. (Pubitemid 44808788)
24. Hui P, Martel M, Parkash V. Gestational trophoblastic diseases: recent advances in histopathologic diagnosis and related genetic aspects. Adv Anat Pathol. 2005;12:116-125. (Pubitemid 40770108)
25. Kurman RJ, Norris HJ. Mesenchymal tumors of the uterus. VI. Epithelioid smooth muscle tumors including leiomyoblastoma and clear-cell leiomyoma: a clinical and pathologic analysis of 26 cases. Cancer. 1976;37:1853-1865.
26. Silva EG, Young RH. Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type. Am J Surg Pathol. 2007;31:1203-1208. (Pubitemid 47207124)
27. Vang R, Kempson RL. Perivascular epithelioid cell tumor ('PEComa') of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors. Am J Surg Pathol. 2002;26:1-13. (Pubitemid 34019987)
28. Clement PB, Young RH. Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol. 2002;9:145-184.
29. Marza VD, Dobresco D. Epithelioma of the uterus with clear cells [in French]. Ann Anat Pathol. 1940;16:1023-1029.
30. Lax SF, Pizer ES, Ronnett BM, et al. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. Hum Pathol. 1998;29:551-558. (Pubitemid 28272707)
31. Yamamoto S, Tsuda H, Aida S, et al. Immunohistochemical detection of hepatocyte nuclear factor 1beta in ovarian and endometrial clear-cell adenocarcinomas and nonneoplastic endometrium. Hum Pathol. 2007;38:1074-1080. (Pubitemid 46899152)
32. Fadare O, Liang SX. Diagnostic utility of hepatocyte nuclear factor 1 beta immunoreactivity in endometrial carcinomas: lack of specificity for endometrial clear cell carcinoma. Appl Immunohistochem Mol Morphol. 2012. [Epub ahead of print].
33. Kenny SL, McBride HA, Jamison J, et al. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-b. Am J Surg Pathol. 2012;36:799-807.
34. Park KJ, Kiyokawa T, Soslow RA, et al. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus. Am J Surg Pathol. 2011;35:633-646.
35. Altrabulsi B, Malpica A, Deavers MT, et al. Undifferentiated carcinoma of the endometrium. Am J Surg Pathol. 2005;29:1316-1321. (Pubitemid 41368767)
36. Silva EG, Deavers MT, Bodurka DC, et al. Association of low grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma? Int J Gynecol Pathol. 2006;25:52-58. (Pubitemid 44638336)
37. Tafe LJ, Garg K, Chew I, et al. Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms. Mod Pathol. 2010;23:781-789.
38. Garg K, Soslow RA. Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma. J Clin Pathol. 2009; 62:679-684.